[Skip to Navigation]
Sign In
Original Investigation
May 26, 2022

Effect of Supine vs Prone Breast Radiotherapy on Acute Toxic Effects of the Skin Among Women With Large Breast Size: A Randomized Clinical Trial

Author Affiliations
  • 1Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
  • 2Department of Radiation Oncology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
  • 3Department of Radiation Oncology, University of British Columbia, BC Cancer Victoria, Victoria, British Columbia, Canada
  • 4Radiation Medicine Program, Stronach Regional Cancer Centre, Southlake Regional Health Centre, Newmarket, Ontario, Canada
  • 5Department of Radiation Oncology, Durham Regional Cancer Centre, Oshawa, Ontario, Canada
  • 6Radiation Oncology, Simcoe Muskoka Regional Cancer Program, Royal Victoria Regional Health Centre, Barrie, Ontario, Canada
  • 7Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
  • 8Department of Physics and Atmospheric Science, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada
JAMA Oncol. 2022;8(7):994-1000. doi:10.1001/jamaoncol.2022.1479
Key Points

Question  Can radiotherapy in the prone position reduce acute toxic effects of the skin in women with large breast size being treated for breast cancer?

Findings  In this randomized clinical trial of 378 patients treated with adjuvant breast radiotherapy, treatment in the prone position was statistically significantly associated with lower rates of moist desquamation (26.9%) compared with treatment in the standard supine position (39.6%).

Meaning  Treatment in the prone position is less toxic than in the supine position in women with large breast size receiving adjuvant breast radiation.

Abstract

Importance  Women with large breast size treated with adjuvant breast radiotherapy (RT) have a high rate of acute toxic effects of the skin. Breast RT in the prone position is one strategy that may decrease these toxic effects.

Objective  To determine if breast RT in the prone position reduces acute toxic effects of the skin when compared with treatment in the supine position.

Design, Setting, and Participants  This phase 3, multicenter, single-blind randomized clinical trial accrued patients from 5 centers across Canada from April 2013 to March 2018 to compare acute toxic effects of breast RT for women with large breast size (bra band ≥40 in and/or ≥D cup) in the prone vs supine positions. A total of 378 patients were referred for adjuvant RT and underwent randomization. Seven patients randomized to supine position were excluded (5 declined treatment and 2 withdrew consent), and 14 patients randomized to prone position were excluded (4 declined treatment, 3 had unacceptable cardiac dose, and 7 were unable to tolerate being prone). Data were analyzed from April 2019 through September 2020.

Interventions  Patients were randomized to RT in the supine or prone position. From April 2013 until June 2016, all patients (n = 167) received 50 Gy in 25 fractions (extended fractionation) with or without boost (range, 10-16 Gy). After trial amendment in June 2016, the majority of patients (177 of 190 [93.2%]) received the hypofractionation regimen of 42.5 Gy in 16 fractions.

Main Outcomes and Measures  Main outcome was moist desquamation (desquamation).

Results  Of the 357 women (mean [SD] age, 61 [9.9] years) included in the analysis, 182 (51.0%) were treated in the supine position and 175 (49.0%) in prone. There was statistically significantly more desquamation in patients treated in the supine position compared with prone (72 of 182 [39.6%] patients vs 47 of 175 [26.9%] patients; OR, 1.78; 95% CI, 1.24-2.56; P = .002), which was confirmed on multivariable analysis (OR, 1.99; 95% CI, 1.48-2.66; P < .001), along with other independent factors: use of boost (OR, 2.71; 95% CI, 1.95-3.77; P < .001), extended fractionation (OR, 2.85; 95% CI, 1.41-5.79; P = .004), and bra size (OR, 2.56; 95% CI, 1.50-4.37; P < .001).

Conclusions and Relevance  This randomized clinical trial confirms that treatment in the prone position decreases desquamation in women with large breast size receiving adjuvant RT. It also shows increased toxic effects using an RT boost and conventional fractionation.

Trial Registration  ClinicalTrials.gov Identifier: NCT01815476

Add or change institution
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×